These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21704888)

  • 1. Safety of formoterol in adults and children with asthma: a meta-analysis.
    Kemp J; Armstrong L; Wan Y; Alagappan VK; Ohlssen D; Pascoe S
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):71-8. PubMed ID: 21704888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
    Cates CJ; Wieland LS; Oleszczuk M; Kew KM
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of formoterol in children and adolescents: experience from asthma clinical trials.
    Price JF; Radner F; Lenney W; Lindberg B
    Arch Dis Child; 2010 Dec; 95(12):1047-53. PubMed ID: 21030368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trials.
    Nelson H; Bonuccelli C; Radner F; Ottosson A; Carroll KJ; Andersson TL; LaForce C
    J Allergy Clin Immunol; 2010 Feb; 125(2):390-396.e8. PubMed ID: 20159250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
    Wickstrøm J; Dam N; Malmberg I; Hansen BB; Lange P
    Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials.
    Sears MR; Ottosson A; Radner F; Suissa S
    Eur Respir J; 2009 Jan; 33(1):21-32. PubMed ID: 18768573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
    Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
    Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials.
    Sears MR; Radner F
    Respir Med; 2009 Dec; 103(12):1960-8. PubMed ID: 19815402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall asthma control: the relationship between current control and future risk.
    Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
    J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
    Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J; Nie B; Xiong W; Xu Y
    J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.